Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,351 | 603 | 94.6% |
| Education | $698.70 | 16 | 5.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,869 | 92 | $0 (2024) |
| Janssen Biotech, Inc. | $1,370 | 60 | $0 (2024) |
| PFIZER INC. | $922.59 | 70 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $807.96 | 49 | $0 (2024) |
| Dornier MedTech America, Inc | $685.18 | 1 | $0 (2023) |
| ABBVIE INC. | $601.72 | 30 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $578.18 | 23 | $0 (2021) |
| Sumitomo Pharma America, Inc. | $497.97 | 26 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $473.22 | 20 | $0 (2024) |
| Allergan, Inc. | $442.14 | 25 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,339 | 57 | Sumitomo Pharma America, Inc. ($175.98) |
| 2023 | $2,453 | 82 | Dornier MedTech America, Inc ($685.18) |
| 2022 | $2,094 | 103 | United Medical Systems (DE), Inc. ($276.61) |
| 2021 | $2,029 | 90 | Astellas Pharma US Inc ($406.96) |
| 2020 | $1,273 | 70 | Astellas Pharma US Inc ($248.52) |
| 2019 | $1,277 | 68 | Astellas Pharma US Inc ($255.28) |
| 2018 | $1,269 | 69 | Astellas Pharma US Inc ($345.88) |
| 2017 | $1,316 | 80 | Astellas Pharma US Inc ($245.47) |
All Payment Transactions
619 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Biological | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Oncology | ||||||
| 10/10/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: HORMONE THERAPY | ||||||
| 10/03/2024 | COLOPLAST CORP | Coloplast TFL Drive (Device) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Endourology | ||||||
| 09/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/25/2024 | Endo USA, Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: UROLOGY | ||||||
| 09/19/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/18/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $40.78 | General |
| Category: rezum_URO | ||||||
| 09/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Oncology | ||||||
| 09/12/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: ONCOLOGY | ||||||
| 09/04/2024 | Olympus America Inc. | Bovie (Device), URETERO-RENO VIDEOSCOPE | Food and Beverage | In-kind items and services | $31.06 | General |
| Category: Urology Gynecology | ||||||
| 08/29/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: UROTHELIAL CANCER | ||||||
| 08/27/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: Oncology | ||||||
| 08/14/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: HORMONE THERAPY | ||||||
| 07/30/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Oncology | ||||||
| 07/17/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $19.65 | General |
| Category: ONCOLOGY | ||||||
| 07/15/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $21.96 | General |
| 07/10/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: ONCOLOGY | ||||||
| 06/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $30.96 | General |
| Category: Oncology | ||||||
| 06/25/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $64.47 | General |
| Category: UROLOGY | ||||||
| 06/20/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Oncology | ||||||
| 06/11/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 2,166 | 2,979 | $609,146 | $178,442 |
| 2022 | 31 | 2,753 | 4,271 | $753,058 | $233,998 |
| 2021 | 35 | 2,936 | 4,579 | $762,592 | $266,210 |
| 2020 | 38 | 3,194 | 5,440 | $738,153 | $272,433 |
All Medicare Procedures & Services
139 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 515 | 601 | $137,629 | $38,240 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 228 | 282 | $90,804 | $24,577 | 27.1% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 23 | 180 | $90,360 | $24,397 | 27.0% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 24 | 312 | $27,456 | $10,729 | 39.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 93 | 93 | $39,153 | $9,873 | 25.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 134 | 140 | $28,140 | $8,896 | 31.6% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 19 | 19 | $27,322 | $8,703 | 31.9% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2023 | 14 | 14 | $24,360 | $7,495 | 30.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 51 | 53 | $26,023 | $6,814 | 26.2% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2023 | 24 | 72 | $12,600 | $4,953 | 39.3% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2023 | 24 | 120 | $10,560 | $4,127 | 39.1% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 12 | 13 | $13,429 | $4,091 | 30.5% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 39 | 40 | $11,320 | $3,372 | 29.8% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Facility | 2023 | 15 | 20 | $8,440 | $2,690 | 31.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 42 | $7,392 | $2,601 | 35.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $6,365 | $1,983 | 31.2% |
| 52281 | Dilation of urethra using an endoscope | Facility | 2023 | 14 | 14 | $5,306 | $1,691 | 31.9% |
| 76998 | Ultrasonic guidance during surgery | Facility | 2023 | 11 | 12 | $5,520 | $1,597 | 28.9% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 14 | 14 | $4,536 | $1,429 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 25 | 25 | $5,725 | $1,322 | 23.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 95 | 107 | $2,889 | $842.04 | 29.1% |
| 87500 | Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | Office | 2023 | 24 | 24 | $2,112 | $825.36 | 39.1% |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | Office | 2023 | 24 | 24 | $2,112 | $825.36 | 39.1% |
| 87641 | Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | Office | 2023 | 24 | 24 | $2,112 | $825.36 | 39.1% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 24 | 24 | $2,112 | $825.36 | 39.1% |
About Dr. Kevin Hackett, M.D
Dr. Kevin Hackett, M.D is a Urology healthcare provider based in Hagerstown, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568419901.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Hackett, M.D has received a total of $13,050 in payments from pharmaceutical and medical device companies, with $1,339 received in 2024. These payments were reported across 619 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($12,351).
As a Medicare-enrolled provider, Hackett has provided services to 11,049 Medicare beneficiaries, totaling 17,269 services with total Medicare billing of $951,083. Data is available for 4 years (2020–2023), covering 139 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Hagerstown, MD
- Active Since 05/30/2006
- Last Updated 03/22/2016
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1568419901
Products in Payments
- XTANDI (Drug) $1,693
- ERLEADA (Drug) $822.71
- XIAFLEX (Biological) $794.60
- GEMTESA (Drug) $725.70
- Dornier MedTech (Device) $685.18
- PROVENGE (Drug) $578.18
- BOTOX (Biological) $577.35
- Nubeqa (Drug) $473.22
- Erleada (Drug) $433.38
- MYRBETRIQ (Drug) $354.49
- Myrbetriq (Drug) $329.09
- ORGOVYX (Drug) $283.71
- JELMYTO (Drug) $241.33
- PROLARIS (Device) $211.30
- NOCDURNA (Drug) $201.80
- LUPRON DEPOT (Drug) $171.85
- ZYTIGA (Drug) $164.50
- GentleCath (Device) $162.29
- Xtandi (Drug) $160.68
- ELIGARD (Drug) $155.64
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Hagerstown
Richard Bryson, M.d, M.D
Urology — Payments: $10,732
Patrick Dennis, M.d, M.D
Urology — Payments: $10,372
Dr. John Maggioncalda, Md, MD
Urology — Payments: $8,625
Wayne Mcwilliams, M.d, M.D
Urology — Payments: $2,943
Mohammad Chaudhry, M.d, M.D
Urology — Payments: $2,726
Dr. Alexander Ernest, Md, MD
Urology — Payments: $237.97